Navigation Links
Sunesis Reports Financial Results for the First Quarter 2009
Date:5/6/2009

me period in 2008. This decrease was primarily due to the termination of substantially all discovery research activities in June 2008.
  • General and administrative expense for the first quarter of 2009 was $2.4 million compared to $3.3 million for the same period in 2008. The decrease was primarily due to reduced administrative headcount as a result of our June 2008 restructuring.
  • Restructuring charges of $1.9 million were recorded in the three months ended March 31, 2009, including $1.3 million for lease termination activities and $0.6 million for employee severance and related benefit costs related to a restructuring in March 2009.
  • Sunesis reported a net loss of $8.4 million for the quarter ended March 31, 2009, compared to a reported net loss of $9.6 million for the same period in 2008.

  • About Voreloxin

    Voreloxin is a first-in-class anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients and in a Phase 1b/2 clinical trial combining voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML, as well as in an ongoing Phase 2 single-agent trial in platinum-resistant ovarian cancer.

    About Acute Myeloid Leukemia

    AML is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is g
    '/>"/>

    SOURCE Sunesis Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
    2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
    3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
    4. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
    5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
    6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
    7. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
    8. Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing
    9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
    10. Haemacure Reports Third Quarter 2007 Results
    11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... Palatine, IL (PRWEB) , ... July 29, 2015 , ... ... the ever-expanding population of children with autism, Little City took a proactive stance and ... and occupied. The Coleman Foundation grant provides valuable support to building the third home. ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Toronto native Douglas James ... Dr. Cottrell has been making predictions about the economy, politics, social issues, as ... these prognostications. He warns that extreme weather conditions and increased earthquake / volcanic ...
    (Date:7/29/2015)... ... 29, 2015 , ... National non-profit World T.E.A.M. Sports announced ... employee benefits and asset management, has joined as presenting sponsor for the inaugural ... Charlotte, North Carolina on October 2-4, 2015. , Hosted at the U.S. ...
    (Date:7/29/2015)... , ... July 29, 2015 , ... ... is seeking funding for a study on the potentially lifesaving impact of removing ... today . , The research proposal is based on a successful pilot ...
    (Date:7/29/2015)... ... ... One may not expect to encounter a kickball game or the sound ... happening on the campus of Piedmont Crossing , a local 60-acre retirement community. ... , a five-star childcare center which operates on the same campus. As many as ...
    Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4
    ... promise to support conscience clausesConscience rights will ... with Administration to advance conscience rights , ... of Chicago, President of the United States ... Obama,s promise to support conscience clauses."Caring health ...
    ... One very famous Texan, the late Byron Nelson, is ... game. With his unprecedented, still-unbroken record of 11 consecutive tournament ... the span of his short 15-year professional career ending in ... strove for excellence not only in sport, but in every ...
    ... virus, genome should make finding a vaccine easier, CDC says ... genes that make up the new H1N1 swine flu virus ... decade, researchers reported Friday. , Scientists at the U.S. Centers ... of more than 50 samples of the swine flu strain ...
    ... Homeless VeteransWASHINGTON, May 22 U.S. Army Captain Scott ... 2009 Conference of the National Coalition for Homeless Veterans ... Division. In 2006, while leading a patrol in ... IED explosion that cost him his right arm and ...
    ... Oklahoma Governor Brad Henry yesterday signed into law H.B. ... ever passed by the Oklahoma legislative and executive branches. ... the comprehensive reform by a vote of 45-1 on ... of Representatives earlier that day by an 86-13 vote. ...
    ... to make vital health and human services available through ... 5,000 people converged on Angel Stadium of Anaheim Saturday, ... HIV/AIDS. Donations from OC AIDS Walk 2009 reached ... living with HIV/AIDS in our community. Thanks to ...
    Cached Medicine News:Health News:Cardinal George Praises President Obama's Promise to Support Conscience Clauses, Seeks to Work With Administration on Goal 2Health News:The Byron Nelson: Championship Philosophy, Timeless Excellence 2Health News:The Byron Nelson: Championship Philosophy, Timeless Excellence 3Health News:Swine Flu Genes Went Undetected for Years: Report 2Health News:Swine Flu Genes Went Undetected for Years: Report 3Health News:Swine Flu Genes Went Undetected for Years: Report 4Health News:Swine Flu Genes Went Undetected for Years: Report 5Health News:Swine Flu Genes Went Undetected for Years: Report 6Health News:Swine Flu Genes Went Undetected for Years: Report 7Health News:Swine Flu Genes Went Undetected for Years: Report 8Health News:Swine Flu Genes Went Undetected for Years: Report 9Health News:Swine Flu Genes Went Undetected for Years: Report 10Health News:Swine Flu Genes Went Undetected for Years: Report 11Health News:Swine Flu Genes Went Undetected for Years: Report 12Health News:Oklahoma Passes Comprehensive Tort Reform: Governor Brad Henry Signs Reform Legislation 2Health News:Thousands Rally in Anaheim to Help People With HIV/AIDS 2
    (Date:7/28/2015)... July 28, 2015   Heska Corporation  (NASDAQ: ... provider of  advanced veterinary diagnostic and other specialty ... the new Element i ® Immunodiagnostic Analyzer. ... for key health concerns, including thyroid disorders, Cushing,s ... a compact bench top analyzer that delivers rapid ...
    (Date:7/28/2015)... 2015  Psychemedics Corporation (NASDAQ: PMD ) today ... June 30, 2015.  The Company also announced a quarterly ... record as of August 7, 2015 to be paid ... 76 th consecutive quarterly dividend. The ... was $7.0 million versus $7.7 million for the quarter ...
    (Date:7/28/2015)... 2015  Nevro Corp. (NYSE: NVRO ), ... innovative evidence-based solutions for the treatment of chronic ... results in the Online First edition of ... of Anesthesiologists. The SENZA-RCT pivotal ... first to directly compare spinal cord stimulation (SCS) ...
    Breaking Medicine Technology:Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2
    ... 18, 2011 Medical Marijuana Inc. (OTC: MJNA) is ... acquire 100% of PharmaSphere, LLC. PharmaSphere, a cutting edge ... of high value bio-compounds sourced from plants that can ... transgenic plants (genetically engineered plants) for the biotechnology revolution ...
    ... SILVER SPRING, Md., Nov. 18, 2011 The U.S. ... Erwinia chrysanthemi ) to treat patients with acute lymphoblastic ... E. coli derived asparaginase and pegaspargase chemotherapy ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Acute lymphoblastic leukemia ...
    Cached Medicine Technology:Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics 2Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics 3Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics 4FDA Approves Erwinaze to Treat a Form of Leukemia 2FDA Approves Erwinaze to Treat a Form of Leukemia 3
    ... motor was specifically developed for use in hand ... orientation is reflected in the design of the ... K-wire chuck and saw attachment, which all allow ... thanks to the systems high torque, it is ...
    ... a truly flexible system offering outstanding levels ... applications, inlcuding orthopedics, abdominal surgery, urology, neurosurgery, ... , ,By offering you a ... memory capacities and a wide range of ...
    The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
    ... from Medennium is an innovative device ... tear duct, and conserve the eye's ... fit a range of punctum sizes. ... material, SmartPLUG adjusts to the exact ...
    Medicine Products: